GSK’s Blenrep combo demonstrates significant survival benefits and improved efficacy in relapsed multiple myeloma compared to Darzalex combo.
GSK’s Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson’s Darzalex
Where Today's News Shapes Tomorrow
